Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Obstructive Lung Diseases

Free Subscription Articles published in Thorax Retrieve available abstracts of 80 articles: HTML format

Single Articles

October 2025
1. LUNDHOLM C, Caffrey Osvald E, Rhedin S, Almqvist C, et al
   Maternal BMI and smoking partly explain the association between maternal socio-economic position and offspring asthma.
   Thorax. 2025 Oct 28:thorax-2025-223330. doi: 10.1136/thorax-2025-223330.
   PubMed     Abstract available
   
   
   
2. XIA Y
   Why asthma progresses to COPD: environmental and genetic drivers.
   Thorax. 2025 Oct 21:thorax-2025-224038. doi: 10.1136/thorax-2025-224038.
   PubMed    
   
   
   
3. LANGLEY R, Corr M, Foster S, Weir E, et al
   New NICE asthma guideline: evidence-based gold standard approach or unachievable utopia?
   Thorax. 2025 Oct 20:thorax-2025-223970. doi: 10.1136/thorax-2025-223970.
   PubMed    
   
   
   
4. KOFOD LM, Hansen EF, Brocki BC, Kristensen MT, et al
   Optimised oxygenation improves functional capacity during daily activities in patients with COPD on long-term oxygen therapy: a randomised crossover trial.
   Thorax. 2025;80:803-809.
   PubMed     Abstract available
   
   
   
5. SHIROSHITA A
   Clarifying the distinct risk factors of atopy and asthma in childhood.
   Thorax. 2025 Oct 8:thorax-2025-223533. doi: 10.1136/thorax-2025-223533.
   PubMed    
   
   
   
6. LIVIERO F
   Occupational asthma: still an underestimated burden?
   Thorax. 2025 Oct 5:thorax-2025-223499. doi: 10.1136/thorax-2025-223499.
   PubMed    
   
   
   
7. KAMINSKY DA
   Home monitoring of asthma using oscillometry: seeking the signal in the noise.
   Thorax. 2025 Oct 5:thorax-2025-223595. doi: 10.1136/thorax-2025-223595.
   PubMed    
   
   
   September 2025
8. ZHANG X, Hartman TJ, Adgent M, Moore P, et al
   Maternal prenatal carotenoids and child lung function: exploration of modifying factors.
   Thorax. 2025;80:748-755.
   PubMed     Abstract available
   
   
   
9. ZHANG W, Chen B, Shima M, Zhao C, et al
   PM(2.5) as a risk factor for sleep oxygen desaturation in COPD: identifying susceptible individuals by smoking and inflammatory phenotypes.
   Thorax. 2025;80:683-692.
   PubMed     Abstract available
   
   
   
10. SYKES DL, Clarkson MD, Negbenebor A, Cummings H, et al
    Impact of regional asthma guidelines on SABA prescribing patterns across England: an interrupted time series analysis.
    Thorax. 2025 Sep 2:thorax-2025-223239. doi: 10.1136/thorax-2025-223239.
    PubMed     Abstract available
    
    
    August 2025
11. KIMURA Y, Jo T, Inoue N, Suzukawa M, et al
    Gabapentinoids and risk for asthma exacerbations: a nationwide retrospective cohort study.
    Thorax. 2025 Aug 24:thorax-2025-223240. doi: 10.1136/thorax-2025-223240.
    PubMed     Abstract available
    
    
    
12. POTTINGER T, Liu Z, Liu L, Buschur KL, et al
    Serum IgA isotypes are associated with percent emphysema, wall thickness and lung function decline.
    Thorax. 2025 Aug 22:thorax-2025-222990. doi: 10.1136/thorax-2025-222990.
    PubMed     Abstract available
    
    
    
13. PEPIN JL, Herquelot E, Denis H, Josseran A, et al
    Impact of long-term non-invasive ventilation on severe exacerbations and survival in COPD: a French nationwide cohort study using multistate models.
    Thorax. 2025;80:616-623.
    PubMed     Abstract available
    
    
    
14. MATHIOUDAKIS AG, Higham A, Bate S, Chatzimavridou-Grigoriadou V, et al
    Reduced treatment response to inhaled corticosteroids in current smokers with COPD, regardless of blood eosinophil count: insights from the FLAME trial.
    Thorax. 2025;80:658-661.
    PubMed     Abstract available
    
    
    July 2025
15. LI G, Zhang K, Yang T, Jin J, et al
    Air pollution, genetic susceptibility and risk of progression from asthma to COPD.
    Thorax. 2025 Jul 21:thorax-2024-222871. doi: 10.1136/thorax-2024-222871.
    PubMed     Abstract available
    
    
    
16. KEMP PR, Griffiths M, Polkey MI, Sathyapala A, et al
    Variability in sensitivity to inflammation in muscle and lung of patients with COPD may underlie susceptibility to lung function decline.
    Thorax. 2025;80:520-529.
    PubMed     Abstract available
    
    
    
17. COLAK Y, Nordestgaard BG, Lange P, Afzal S, et al
    Sex differences in COPD in relation to smoking exposure: a population-based cohort study.
    Thorax. 2025;80:512-519.
    PubMed     Abstract available
    
    
    June 2025
18. RUTTER CE, Mpairwe H, Figueiredo CA, Njoroge M, et al
    Risk factors for atopic and non-atopic asthma in school-age children from high-income and low- and middle-income countries.
    Thorax. 2025 Jun 24:thorax-2024-222118. doi: 10.1136/thorax-2024-222118.
    PubMed     Abstract available
    
    
    
19. HOANG MT, Wong A, Hardaker K, Peiris S, et al
    Day-to-day variability indices improve utility of oscillometry in paediatric asthma.
    Thorax. 2025 Jun 24:thorax-2024-222744. doi: 10.1136/thorax-2024-222744.
    PubMed     Abstract available
    
    
    
20. JIANG M, Zhang Y, Liu T, Hong X, et al
    Circulating miRNAs and childhood asthma ICS response: a stratified analysis in the intervention arm of an RCT with vitamin D effect modification.
    Thorax. 2025 Jun 4:thorax-2024-222618. doi: 10.1136/thorax-2024-222618.
    PubMed     Abstract available
    
    
    May 2025
21. USMANI O, Verbanck S
    Structure-function-treatment relationships of aerosol deposition in patients with severe asthma.
    Thorax. 2025 May 22:thorax-2025-223228. doi: 10.1136/thorax-2025-223228.
    PubMed    
    
    
    
22. KHOR YH, Palm A, Wong AW, Guler SA, et al
    Effects of long-term oxygen therapy on acute exacerbation and hospital burden: the national DISCOVERY study.
    Thorax. 2025;80:378-384.
    PubMed     Abstract available
    
    
    
23. KNOX-BROWN B, Kon FC, Sylvester KP, Jha A, et al
    Effect of time of day and seasonal variation on bronchodilator responsiveness: the SPIRO-TIMETRY study.
    Thorax. 2025;80:395-397.
    PubMed     Abstract available
    
    
    April 2025
24. ALIF SM, Benke G, Kromhout H, Abramson MJ, et al
    Occupational exposures and incidence of asthma over two decades in the European Community Respiratory Health Survey.
    Thorax. 2025 Apr 29:thorax-2024-222307. doi: 10.1136/thorax-2024-222307.
    PubMed     Abstract available
    
    
    
25. RUPANI H
    Is this the unified asthma guideline we've been waiting for?
    Thorax. 2025 Apr 24:thorax-2025-223056. doi: 10.1136/thorax-2025-223056.
    PubMed    
    
    
    
26. BERGMANN M, Andersen ZJ, Massling A, Loft S, et al
    Short-term exposure to ultrafine particles and asthma hospital admissions in children in Copenhagen, Denmark.
    Thorax. 2025 Apr 24:thorax-2024-222465. doi: 10.1136/thorax-2024-222465.
    PubMed     Abstract available
    
    
    
27. 
    BTS/NICE/SIGN joint guideline on asthma: diagnosis, monitoring and chronic asthma management (November 2024) - summary of recommendations.
    Thorax. 2025 Apr 24:thorax-2024-222910. doi: 10.1136/thorax-2024-222910.
    PubMed    
    
    
    
28. WANG R, Maidstone R, Singh D, Ray D, et al
    The impact of dosage timing for inhaled corticosteroids in asthma: a randomised three-way crossover trial.
    Thorax. 2025 Apr 15:thorax-2024-222073. doi: 10.1136/thorax-2024-222073.
    PubMed     Abstract available
    
    
    
29. SMALLCOMBE N, Russell RE
    Chronotherapy in asthma: BD or not BD? That is the question.
    Thorax. 2025 Apr 15:thorax-2025-223094. doi: 10.1136/thorax-2025-223094.
    PubMed    
    
    
    
30. CHO EE, Maclagan LC, Chu A, Croxford R, et al
    Impact of COPD on cardiovascular risk factors and outcomes in people with established cardiovascular disease.
    Thorax. 2025;80:291-299.
    PubMed     Abstract available
    
    
    
31. MARCALO R, Rodrigues G, Pinheiro M, Neto S, et al
    Functional impairment in COPD can be predicted using genomic-derived data.
    Thorax. 2025;80:283-290.
    PubMed     Abstract available
    
    
    
32. WHITTAKER H, Kramer Fiala Machado A, Hatam S, Cook S, et al
    Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland.
    Thorax. 2025 Apr 8:thorax-2024-222699. doi: 10.1136/thorax-2024-222699.
    PubMed     Abstract available
    
    
    March 2025
33. RAGUNAYAKAM N, Thakar A, Sadafi H, Venegas Garrido C, et al
    Computational fluid dynamics model predictions of inhaled corticosteroid deposition in patients with severe asthma.
    Thorax. 2025 Mar 27:thorax-2024-222444. doi: 10.1136/thorax-2024-222444.
    PubMed     Abstract available
    
    
    
34. POLLOCK J, Polverino E, Dhar R, Dimakou K, et al
    Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Thorax. 2025 Mar 23:thorax-2024-221825. doi: 10.1136/thorax-2024-221825.
    PubMed     Abstract available
    
    
    
35. MUBANGA M, Gong T, Smew AI, Wikstrom A, et al
    Association between asthma and type 2 diabetes in a Swedish adult population: a register-based cross-sectional study.
    Thorax. 2025 Mar 23:thorax-2024-222819. doi: 10.1136/thorax-2024-222819.
    PubMed     Abstract available
    
    
    
36. STORGAARD PETERSEN R, Hallas H, Brustad N, Chawes B, et al
    Short-term efficacy of inhaled short-acting beta-2-agonists for acute wheeze/asthma symptoms in preschool-aged children: a systematic review and meta-analysis.
    Thorax. 2025 Mar 23:thorax-2024-222760. doi: 10.1136/thorax-2024-222760.
    PubMed     Abstract available
    
    
    
37. THOMPSON C, Middleton PG
    Inhaled corticosteroids may be useful in bronchiectasis with peripheral blood eosinophilia.
    Thorax. 2025 Mar 23:thorax-2025-223053. doi: 10.1136/thorax-2025-223053.
    PubMed    
    
    
    
38. RAVELING T, Boersma R, Wijkstra PJ, Duiverman ML, et al
    Clinical benefit of chronic non-invasive ventilation in severe stable COPD: a matter of persistent hypercapnia improvement.
    Thorax. 2025;80:202-208.
    PubMed     Abstract available
    
    
    
39. GLOECKL R, Spielmanns M, Stankeviciene A, Plidschun A, et al
    Smartphone application-based pulmonary rehabilitation in COPD: a multicentre randomised controlled trial.
    Thorax. 2025;80:209-217.
    PubMed     Abstract available
    
    
    
40. MACHADO A, Dias C, Paixao C, Goncalves AP, et al
    Short-term effects of home-based pulmonary rehabilitation during outpatient-managed exacerbations of COPD: a randomised controlled trial.
    Thorax. 2025;80:218-226.
    PubMed     Abstract available
    
    
    
41. BAILEY G, Ridge CA
    Pulmonary microvascular blood volume and emphysema: in vivo link shown in the MESA cohort.
    Thorax. 2025 Mar 13:thorax-2025-223133. doi: 10.1136/thorax-2025-223133.
    PubMed    
    
    
    
42. BAE E, Park HJ, Park H, Lee JK, et al
    Early clinical remission and its role in lung function decline and exacerbation in adult Korean patients with asthma.
    Thorax. 2025 Mar 6:thorax-2024-222679. doi: 10.1136/thorax-2024-222679.
    PubMed     Abstract available
    
    
    February 2025
43. KIVISTO JE, Protudjer JLP, Ekstrom S, Karjalainen J, et al
    Adult asthma hospitalisations decreased markedly in Finland and Sweden between 2006 and 2022.
    Thorax. 2025 Feb 8:thorax-2024-222417. doi: 10.1136/thorax-2024-222417.
    PubMed     Abstract available
    
    
    January 2025
44. IOANNIDES AE, Kallis C, Whittaker HR, Quint JK, et al
    Inhaled corticosteroids and major cardiovascular events in people with chronic obstructive pulmonary disease.
    Thorax. 2025;80:67-75.
    PubMed     Abstract available
    
    
    
45. VAN DER VEER T, Andrinopoulou ER, Braunstahl GJ, Charbonnier JP, et al
    Association between automatic AI-based quantification of airway-occlusive mucus plugs and all-cause mortality in patients with COPD.
    Thorax. 2025;80:105-108.
    PubMed     Abstract available
    
    
    
46. DOUMAT G, El Zein J, Mehta GD, Zhu Z, et al
    Association between vitamin D status at 3 years and eosinophilic asthma in 6-year-old children with a history of severe bronchiolitis.
    Thorax. 2025 Jan 6:thorax-2024-222099. doi: 10.1136/thorax-2024-222099.
    PubMed     Abstract available
    
    
    December 2024
47. HERRON M, Roche S, Fraughen DD, Heeney RC, et al
    Optimising bronchoalveolar lavage: lessons from alpha-1 antitrypsin deficiency.
    Thorax. 2024;80:24-31.
    PubMed     Abstract available
    
    
    
48. LAVOIE G, Howell I, Melhorn J, Borg C, et al
    Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment.
    Thorax. 2024 Dec 18:thorax-2024-221977. doi: 10.1136/thorax-2024-221977.
    PubMed     Abstract available
    
    
    
49. GRAUL EL, Janson C
    Cost-related nonadherence to medication among people with asthma in the United States: findings that reinforce the relevance of history and healthcare reform.
    Thorax. 2024 Dec 9:thorax-2024-222662. doi: 10.1136/thorax-2024-222662.
    PubMed    
    
    
    
50. HUNG CT, Erickson SR, Wu CH
    Cost-related non-adherence to medications among adults with asthma in the USA, 2011-2022.
    Thorax. 2024 Dec 9:thorax-2024-221778. doi: 10.1136/thorax-2024-221778.
    PubMed     Abstract available
    
    
    November 2024
51. PALJARVI T, Forton JT, Thompson C, Luciano S, et al
    Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma.
    Thorax. 2024 Nov 22:thorax-2024-221590. doi: 10.1136/thorax-2024-221590.
    PubMed     Abstract available
    
    
    
52. EVANGELOPOULOS D, Zhang H, Chatzidiakou L, Walton H, et al
    Air pollution and respiratory health in patients with COPD: should we focus on indoor or outdoor sources?
    Thorax. 2024;79:1116-1123.
    PubMed     Abstract available
    
    
    
53. HERMANN EA, Motahari A, Hoffman EA, Sun Y, et al
    Associations of pulmonary microvascular blood volume with per cent emphysema and CT emphysema subtypes in the community: the MESA Lung study.
    Thorax. 2024 Nov 4:thorax-2024-222002. doi: 10.1136/thorax-2024-222002.
    PubMed     Abstract available
    
    
    October 2024
54. YEN FS, Hsu CC, Wei JC, Tsai FJ, et al
    Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD.
    Thorax. 2024;79:1017-1023.
    PubMed     Abstract available
    
    
    
55. PHILIP J, Chang YK, Collins A, Smallwood N, et al
    Consensus palliative care referral criteria for people with chronic obstructive pulmonary disease.
    Thorax. 2024;79:1006-1016.
    PubMed     Abstract available
    
    
    
56. LO D, Lawson C, Gillies C, Shabnam S, et al
    Association between socioeconomic deprivation, ethnicity and health outcomes in preschool children with recurrent wheeze in England: a retrospective cohort study.
    Thorax. 2024;79:1050-1059.
    PubMed     Abstract available
    
    
    September 2024
57. FILIPOW N, Turner S, Petsky HL, Chang AB, et al
    Variability in forced expiratory volume in 1 s in children with symptomatically well-controlled asthma.
    Thorax. 2024 Sep 27:thorax-2024-221755. doi: 10.1136/thorax-2024-221755.
    PubMed     Abstract available
    
    
    
58. BRUSTAD N, Thorsen J, Pedersen CET, Ali M, et al
    Urban metabolic and airway immune profiles increase the risk of infections in early childhood.
    Thorax. 2024;79:943-952.
    PubMed     Abstract available
    
    
    August 2024
59. NORDLUND B
    Inequalities in care and the burden of wheeze and asthma in young children from diverse socioeconomic and ethnic backgrounds.
    Thorax. 2024 Aug 17:thorax-2024-222111. doi: 10.1136/thorax-2024-222111.
    PubMed    
    
    
    July 2024
60. TATON O, Gevenois PA, Van Muylem A, Bondue B, et al
    Improvements of the shape and strength of the diaphragm after endoscopic lung volume reduction.
    Thorax. 2024;79:711-717.
    PubMed     Abstract available
    
    
    
61. LICSKAI C, Hussey A, Rowley V, Ferrone M, et al
    Quantifying sustained health system benefits of primary care-based integrated disease management for COPD: a 6-year interrupted time series study.
    Thorax. 2024;79:725-734.
    PubMed     Abstract available
    
    
    
62. GERSHON AS, Blazer A, Ko D
    Undertreating cardiovascular disease in people with chronic obstructive pulmonary disease (COPD).
    Thorax. 2024;79:705-706.
    PubMed    
    
    
    
63. GRANELL R, Haider S, Deliu M, Ullah A, et al
    Lung function trajectories from school age to adulthood and their relationship with markers of cardiovascular disease risk.
    Thorax. 2024;79:770-777.
    PubMed     Abstract available
    
    
    
64. AMEGADZIE JE, Gao Z, Quint JK, Russell R, et al
    QRISK3 underestimates the risk of cardiovascular events in patients with COPD.
    Thorax. 2024;79:718-724.
    PubMed     Abstract available
    
    
    
65. KARP T, Faiz A, van Nijnatten J, Kerstjens HAM, et al
    Nasal epithelial gene expression identifies relevant asthma endotypes in the ATLANTIS study.
    Thorax. 2024 Jul 15:thorax-2023-221230. doi: 10.1136/thorax-2023-221230.
    PubMed     Abstract available
    
    
    May 2024
66. GHOSH M, Vladar EK
    Extensive airway remodelling in severe COPD imparts resiliency to environmental stressors.
    Thorax. 2024;79:491-492.
    PubMed    
    
    
    
67. KOEFOED HJL, Wang G, Gehring U, Ekstrom S, et al
    Clinical implications of airway obstruction with normal or low FEV(1) in childhood and adolescence.
    Thorax. 2024;79:573-580.
    PubMed     Abstract available
    
    
    
68. LIANG C, Chung HF, Dobson A, Sandin S, et al
    Female reproductive histories and the risk of chronic obstructive pulmonary disease.
    Thorax. 2024;79:508-514.
    PubMed     Abstract available
    
    
    
69. STOLERIU MG, Ansari M, Strunz M, Schamberger A, et al
    COPD basal cells are primed towards secretory to multiciliated cell imbalance driving increased resilience to environmental stressors.
    Thorax. 2024;79:524-537.
    PubMed     Abstract available
    
    
    April 2024
70. JENKINS AR, Burtin C, Camp PG, Lindenauer P, et al
    Do pulmonary rehabilitation programmes improve outcomes in patients with COPD posthospital discharge for exacerbation: a systematic review and meta-analysis.
    Thorax. 2024;79:438-447.
    PubMed     Abstract available
    
    
    
71. WU T, Santos S, Quezada-Pinedo HG, Vernooij MW, et al
    Body composition and respiratory outcomes in children: a population-based prospective cohort study.
    Thorax. 2024;79:448-456.
    PubMed     Abstract available
    
    
    
72. GRUDZINSKA FS, Scott A
    Unravelling the neutrophil enigma: a new insight into RSV-induced bronchiolitis in infants.
    Thorax. 2024 Apr 4:thorax-2023-221130. doi: 10.1136/thorax-2023-221130.
    PubMed    
    
    
    March 2024
73. PETOUSI N, Pavord ID, Kent BD
    Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease.
    Thorax. 2024;79:291-292.
    PubMed    
    
    
    
74. CELIS-PRECIADO CA, Lachapelle P, Couillard S
    Blood eosinophils take centre stage in predicting the response to sublingual immunotherapy (SLIT): a familiar twist.
    Thorax. 2024;79:297-298.
    PubMed    
    
    
    
75. VOGIATZIS I
    Role of blood flow restriction strength training in chronic obstructive pulmonary disease.
    Thorax. 2024;79:289-290.
    PubMed    
    
    
    
76. COLAK Y, Afzal S, Marott JL, Vestbo J, et al
    Type-2 inflammation and lung function decline in chronic airway disease in the general population.
    Thorax. 2024;79:349-358.
    PubMed     Abstract available
    
    
    
77. KOHLBRENNER D, Kuhn M, Manettas A, Aregger C, et al
    Low-load blood flow restriction strength training in patients with COPD: a randomised single-blind pilot study.
    Thorax. 2024;79:340-348.
    PubMed     Abstract available
    
    
    
78. WANG KCW, Blakey JD
    Impacts of sex and gender on severe asthma.
    Thorax. 2024 Mar 7:thorax-2023-221117. doi: 10.1136/thorax-2023-221117.
    PubMed    
    
    
    
79. MORGAN AD
    Unravelling the obesity-asthma connection in childhood and adolescence: does body shape matter?
    Thorax. 2024 Mar 7:thorax-2023-221345. doi: 10.1136/thorax-2023-221345.
    PubMed    
    
    
    February 2024
80. WILKINSON AJK, Maslova E, Janson C, Radhakrishnan V, et al
    Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study.
    Thorax. 2024 Feb 27:thorax-2023-220259. doi: 10.1136/thorax-2023-220259.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Obstructive Lung Diseases is free of charge.